142 related articles for article (PubMed ID: 6206322)
1. Myocardial uptake of encainide and its two major metabolites, O-demethyl encainide and 3-methoxy-O-demethyl encainide, in the dog.
Latini R; Gillis AM; Kates RE
J Cardiovasc Pharmacol; 1984; 6(4):663-7. PubMed ID: 6206322
[TBL] [Abstract][Full Text] [Related]
2. Comparative antiarrhythmic actions of encainide and its major metabolites.
Gomoll AW; Byrne JE; Mayol RF
Arch Int Pharmacodyn Ther; 1986 Jun; 281(2):277-97. PubMed ID: 3092755
[TBL] [Abstract][Full Text] [Related]
3. The effects of encainide and its major metabolites, O-demethyl encainide and 3-methoxy-O-demethyl encainide, on experimental cardiac arrhythmias in dogs.
Kerr MJ; Allen JD; Harron DW; Shanks RG
J Cardiovasc Pharmacol; 1985; 7(3):449-57. PubMed ID: 2410673
[TBL] [Abstract][Full Text] [Related]
4. Qualitative and quantitative comparison of the cardiac effects of encainide and its three major metabolites in the dog.
Davy JM; Dorian P; Kantelip JP; Harrison DC; Kates RE
J Pharmacol Exp Ther; 1986 Jun; 237(3):907-11. PubMed ID: 3086540
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in man.
Barbey JT; Thompson KA; Echt DS; Woosley RL; Roden DM
Circulation; 1988 Feb; 77(2):380-91. PubMed ID: 3123092
[TBL] [Abstract][Full Text] [Related]
6. Metabolite cumulation during long-term oral encainide administration.
Kates RE; Harrison DC; Winkle RA
Clin Pharmacol Ther; 1982 Apr; 31(4):427-32. PubMed ID: 6800679
[TBL] [Abstract][Full Text] [Related]
7. Effects of encainide and its metabolites on energy requirements for defibrillation.
Fain ES; Dorian P; Davy JM; Kates RE; Winkle RA
Circulation; 1986 Jun; 73(6):1334-41. PubMed ID: 3084128
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of O-demethyl encainide on induced and spontaneous arrhythmias in the conscious dog.
Dawson AK; Roden DM; Duff HJ; Woosley RL; Smith RF
Am J Cardiol; 1984 Sep; 54(6):654-8. PubMed ID: 6475789
[TBL] [Abstract][Full Text] [Related]
9. Depression of maximum rate of depolarization of guinea-pig ventricular action potentials by metabolites of encainide.
Hemsworth PD; Campbell TJ
Br J Pharmacol; 1989 Jun; 97(2):619-25. PubMed ID: 2503225
[TBL] [Abstract][Full Text] [Related]
10. Oxidative metabolism of encainide: polymorphism, pharmacokinetics and clinical considerations.
McAllister CB; Wolfenden HT; Aslanian WS; Woosley RL; Wilkinson GR
Xenobiotica; 1986 May; 16(5):483-90. PubMed ID: 3090789
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and metabolism of encainide.
Jaillon P
Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():561-5. PubMed ID: 2125833
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological effects of encainide and its metabolites in normal canine Purkinje fibers and Purkinje fibers surviving infarction.
Kinnaird AA; Man RY
Can J Physiol Pharmacol; 1989 Jul; 67(7):751-6. PubMed ID: 2504469
[TBL] [Abstract][Full Text] [Related]
13. Encainide: a new antiarrhythmic agent.
Wehmeyer AE; Thomas RL
Drug Intell Clin Pharm; 1986 Jan; 20(1):9-13. PubMed ID: 3080301
[TBL] [Abstract][Full Text] [Related]
14. [Acute and long-term antiarrhythmia effect of encainide in chronic atrial extrasystole].
Thale J; Klein H; Shanks RG; Bender F
Z Kardiol; 1985 Apr; 74(4):220-7. PubMed ID: 2408392
[TBL] [Abstract][Full Text] [Related]
15. Drug interaction studies and encainide use in renal and hepatic impairment.
Quart BD; Gallo DG; Sami MH; Wood AJ
Am J Cardiol; 1986 Aug; 58(5):104C-113C. PubMed ID: 2875643
[TBL] [Abstract][Full Text] [Related]
16. Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals.
Carey EL; Duff HJ; Roden DM; Primm RK; Wilkinson GR; Wang T; Oates JA; Woosley RL
J Clin Invest; 1984 Feb; 73(2):539-47. PubMed ID: 6421879
[TBL] [Abstract][Full Text] [Related]
17. Analysis of encainide and metabolites in plasma and urine by high-performance liquid chromatography.
Bartek MJ; Mayol RF; Boarman MP; Gammans RE; Gallo DG
Ther Drug Monit; 1988; 10(4):446-52. PubMed ID: 3144068
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiology, hemodynamic and arrhythmia efficacy model studies on encainide.
Gomoll AW; Byrne JE; Antonaccio MJ
Am J Cardiol; 1986 Aug; 58(5):10C-17C. PubMed ID: 3092614
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiologic actions of O-demethyl encainide: an active metabolite.
Duff HJ; Dawson AK; Roden DM; Oates JA; Smith RF; Woosley RL
Circulation; 1983 Aug; 68(2):385-91. PubMed ID: 6861313
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of encainide.
Roden DM; Woosley RL
Clin Pharmacokinet; 1988 Mar; 14(3):141-7. PubMed ID: 3131058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
